Gummy smile—excessive gingival display exceeding 3-4mm during smiling—affects 10-15% of the population and represents one of the most common aesthetic complaints driving cosmetic dental consultation. The condition results from multiple etiologic factors, each requiring distinct treatment approach. This comprehensive guide addresses diagnostic classification, measurement standardization, and evidence-based treatment protocols for optimal aesthetic and functional outcomes.

Gummy Smile Diagnosis and Aesthetic Standards

Ideal gingival display during smiling ranges 1-3mm according to aesthetic standards, though individual variation exists. Measurements exceeding 3-4mm constitute pathologic gummy smile requiring treatment evaluation. Asymmetric gingival display exceeding 2mm between quadrants should prompt investigation of underlying asymmetric skeletal or soft tissue factors.

Clinical examination under standardized lighting conditions with relaxed and posed smiling establishes baseline gingival display. Digital photography with consistent angulation, magnification, and positioning enables objective documentation and progress monitoring. Three-dimensional smile analysis using digital photography from frontal and oblique views assesses lip position, buccal corridors, and molar display.

Intraoral examination documents: tooth length-to-width ratios, gingival contours, periodontal health, frenum position and density, and vertical dimension of face. Extraoral assessment includes: lip length (measured from subnasale to labiale inferius), vermillion display at rest, and lip support during smiling.

Cone beam computed tomography (CBCT) imaging quantifies skeletal relationships and bone anatomy essential for treatment planning. Three-dimensional bone reconstruction enables precise assessment of vertical maxillary excess, anterior alveolar bone height, and furcation morphology guiding surgical approach selection.

Etiology Classification and Incidence

Gummy smile etiology classification identifies treatable factors guiding treatment selection. Research estimates the following prevalence among gummy smile patients:

Altered Passive Eruption (12%): Teeth erupted to maximal extent but gingival margins remain apical to ideal position, exposing excessive clinical crown. The gingival zenith (highest point of gingival margin) typically positions at incisor-canine junction. In altered passive eruption, gingival margins remain lower, exposing significant tooth length. Gingival tissue remains healthy with normal probing depths (1-3mm), distinguishing from disease-related changes. Etiology involves excessive gingival/periodontal architecture—normal tooth eruption but persistent covering by thicker gingival biotype. Vertical Maxillary Excess (20%): Increased anterior facial height relative to posterior dimensions creates skeletal discrepancy. Anterior maxilla extends vertically excessively, positioning incisor edge apically and increasing gingival display without dentoalveolar abnormality. CBCT confirms anterior maxillary vertical hypermobility and excessive intergingival distance (measured from incisor edge to molar cusp tip apex, typically 48-52mm in normal occlusion; VME exceeds 52-58mm). Short Upper Lip (15%): Inadequate vermillion coverage of anterior teeth during smiling—lip length insufficient (normally 22-24mm) to cover gingival margins during smile. The lip elevation amount during smile averages 7-8mm; short lips elevate excessively relative to lip length, exposing gingiva. Hypermobile Lip (35%): Excessive upper lip elevation during smiling—averaging >8mm vertical movement instead of typical 7-8mm. The levator labii superioris and associated muscles contract excessively, creating excessive gingival display despite normal lip length, tooth position, and skeletal anatomy. This most common etiology requires different treatment approach (muscle relaxation via Botox rather than osseous surgery). Combined Factors: Many gummy smile patients demonstrate multiple contributing factors—altered passive eruption with short lip, or VME with hypermobile lip. Treatment planning must address all identified contributors for optimal outcomes.

Crown Lengthening with Osseous Recontouring

Crown lengthening with osseous recontouring addresses altered passive eruption by establishing ideal gingival margin position through controlled bone reduction. This periodontal surgical procedure removes bone crest 3-4mm apical to desired gingival margin position, allowing physiologic migration of gingival margin to new bone level.

Surgical technique involves partial-thickness flap elevation to expose alveolar crest. Supracrestal bone (bone apical to alveolar crest extending toward root apex) is removed with burs and hand instruments, maintaining 3-4mm supracrestal tissue space (biological width) between bone crest and desired gingival margin position. Internal bevel incisions and simplified flap design facilitate healing and minimize scarring.

Esthetic outcomes depend critically on achieving balanced anterior gingival display and ideal scallop contours. Excessive bone removal risks gingival recession in healed state. Insufficient removal fails to achieve desired gingival height. Multiple tooth involvement requires careful contouring maintaining anatomic gingival architecture.

Healing occurs over 3-6 months with complete gingival remodeling and margin stabilization. Temporary aesthetic compromise occurs immediately post-operatively as flaps heal and gingival contours remodel. Patient education regarding healing timeline prevents dissatisfaction during remodeling phase.

Vertical Maxillary Excess: Orthognathic Correction

Vertical maxillary excess causing disproportionate vertical facial proportions requires orthognathic surgical correction through LeFort I impaction—superior repositioning of maxilla establishing normal vertical facial relationships.

LeFort I osteotomy involves horizontal cut through maxilla above tooth roots, separating maxilla from skull base. Precise impaction (upward movement) of maxilla is achieved through fixation at level required to establish normal incisor-to-molar vertical relationship and ideal gingival display. The procedure typically impacts maxilla 3-8mm depending on skeletal deformity severity.

This comprehensive surgical procedure addresses not only gingival display but also other vertical maxillary excess manifestations: anterior open bite, long lower facial height, and obtuse nasolabial angle. Treatment requires orthodontic therapy before and after surgery (typically 18-24 months total duration), periodic follow-up, and acceptance of potential complications (neurosensory changes, relapse).

Alternatives to surgical impaction for mild cases include transosteal distraction osteogenesis—gradual bone repositioning through traction force applied to distraction devices. Superior results occur with slower distraction rate (1mm daily after 5-7 day latency period) over 2-3 week duration.

Short Upper Lip: Surgical Repositioning

Short upper lip (inadequate length) causing excessive gingival display may be treated surgically through lip lengthening or repositioning procedures. Surgical options include: lip advancement (moving lip mucosa superiorly), V-Y flap advancement increasing lip-to-teeth distance, or limited surgical modification of buccal frenum reducing lip tension.

Limited frenum surgery addresses excessive frenum thickness and short frenum limiting lip elevation. Frenectomy or frenum repositioning lowers frenum insertion, allowing greater lip mobility and elevation potential. This minor procedure shows variable efficacy depending on frenum contribution to lip restriction.

More definitive short lip correction requires myotomy of levator muscles combined with soft tissue grafting or flap advancement. The complexity and potential morbidity of these procedures limit widespread adoption. Patients should carefully consider potential scarring, altered sensation, and modest aesthetic gains relative to invasive nature.

Hypermobile Lip: Botulinum Toxin Injection

Hypermobile upper lip (excessive vertical movement during smiling) responds excellently to botulinum toxin injection into levator muscles elevating the lip. Injection sites target: levator labii superioris, levator labii superioris alaeque nasi (LLSAN), and zygomaticus major muscles controlling lip elevation.

Standard doses range 2.5-5 units per muscle group per side (total 5-15 units bilateral), titrated based on patient anatomy and desired effect. Higher doses reduce lip elevation more dramatically, potentially overcorrecting to unnatural flattened smile. Lower doses provide subtle reduction maintaining natural expression. Most injectors employ 4-5 units per side of LLSAN as starting point, adjusting based on response.

Onset of effect occurs 3-7 days post-injection, with maximal effect at 2-3 weeks. Duration averages 3-4 months, requiring periodic re-injection for maintained effect. Patients achieve reversibility if dissatisfied—effects dissipate without intervention.

Complications remain minimal but include: bruising at injection sites (2-5% incidence), temporary numbness or paresthesia, asymmetric smile if injection technique inadequate, and rare lip weakness if higher doses inadvertently diffuse to orbicularis oris. Careful injection technique and conservative dosing minimize complications.

Cost considerations include: $300-600 per treatment (3-4 month duration), requiring 3-4 treatments annually for sustained effect—approximately $1200-2400 yearly. This substantially exceeds surgical alternatives though avoids surgical morbidity and recovery time.

Combination Therapy Approaches

Most cases benefit from combination approaches addressing multiple etiologic factors simultaneously. Patients with altered passive eruption plus hypermobile lip require both crown lengthening and Botox for optimal results. Vertical maxillary excess with short lip may require orthognathic impaction combined with Botox injection or lip advancement.

Treatment sequencing determines outcomes. Minor gingival display correction through Botox injection first allows assessment of goal achievement before invasive surgical intervention. If Botox alone insufficient after 2-3 treatment cycles, surgical correction proceeds with benefit of clarified goals and realistic expectation adjustment.

Alternatively, surgical correction precedes Botox injection when significant skeletal or dental correction is required. Definitive surgical repositioning establishes baseline gingival display, then Botox fine-tunes result if minor hypermobility persists.

TAD-Assisted Intrusion for Mild VME

Temporary anchorage devices (TADs) enable intrusion of maxillary anterior teeth through orthodontic force, effectively reducing gingival display without surgical skeletal changes. This approach reserves orthognathic surgery for severe cases while providing orthodontically achievable reduction in mild vertical maxillary excess.

TAD placement in palatal mucosa with force application to anterior teeth achieves gradual intrusion over 4-6 months. Modest vertical correction (2-3mm) is achievable before TAD removal and retention phase. Esthetic crown height increases through intrusion, partially offsetting modest vertical skeletal discrepancy.

Digital Treatment Planning and Smile Design

Digital smile design utilizing patient photographs and digitally-modified images improves patient communication and goal alignment. Software tools enable simulation of proposed gingival display modifications, tooth shade changes, and smile arc adjustments. Showing patients digitally-modified images with their proposed gingival display during smile consultation improves realistic expectation establishment.

Three-dimensional CBCT-based treatment planning enables precise surgical planning for crown lengthening, orthognathic correction, or distraction osteogenesis. Virtual surgical repositioning simulation allows accurate bone cutting guides and fixation planning.

Conclusion

Gummy smile diagnosis requires systematic classification identifying predominant etiologic factors guiding treatment selection. Altered passive eruption responds optimally to periodontal crown lengthening with osseous recontouring. Vertical maxillary excess necessitates orthognathic LeFort I impaction establishing normal facial proportions. Short upper lip may benefit from surgical repositioning though results are variable and technique-dependent. Hypermobile lip represents the most common etiology responding excellently to botulinum toxin injection (2.5-5 units per side into LLSAN) with 3-4 month duration. Combination therapies addressing multiple etiologic factors simultaneously provide superior outcomes compared to single-modality treatment. Digital smile design facilitates treatment planning and patient communication. Treatment selection balances invasiveness, cost, durability, and reversibility with individual patient factors. Comprehensive digital treatment planning incorporating CBCT imaging and three-dimensional analysis optimizes treatment planning and patient satisfaction.